ScholarIQanswers from OpenAlex & ORCID
Laurie Elit
ResearcherPublications, citations & collaboration network
Laurie Elit is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Laurie Elit have?
ScholarIQindexed works
Laurie Elit has 204 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Laurie Elit have?
ScholarIQcitation count
Laurie Elit has 7,250 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Laurie Elit?
ScholarIQh-index
Laurie Elit has an h-index of 40 in OpenAlex.
What is the i10-index of Laurie Elit?
ScholarIQi10-index
Laurie Elit has an i10-index of 92 in OpenAlex.
What is the ORCID of Laurie Elit?
ScholarIQorcid
The ORCID for Laurie Elit is on the source record.
What is the OpenAlex record for Laurie Elit?
ScholarIQopenalex
The OpenAlex for Laurie Elit is on the source record.
What are the most-cited papers on Laurie Elit?
ScholarIQmost cited works
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
Robert L. Coleman, Amit M. Oza, Domenica Lorusso, Carol Aghajanian, Ana Oaknin, Andrew Dean, Nicoletta Colombo, Johanne I. Weberpals, Andrew R. Clamp, Giovanni Scambia, Alexandra Léary, Robert W. Holloway, Margarita Amenedo, Peter C.C. Fong, Jeffrey C. Goh, David M. O’Malley, Deborah K. Armstrong, Jesús García-Donás, Elizabeth M. Swisher, Anne Floquet, Gottfried E. Konecny, Iain A. McNeish, Clare L. Scott, T. Cameron, Lara Maloney, Jeff Isaacson, Sandra Goble, Caroline A. Grace, Thomas C. Harding, Mitch Raponi, James Sun, Kevin Lin, Heidi Giordano, Jonathan A. Ledermann, Martin Buck, Andrew Dean, Michael Friedländer, Jeffrey C. Goh, Paul R. Harnett, Ganessan Kichenadasse, Clare L. Scott, Hannelore Denys, Luc Dirix, Ignace Vergote, Laurie Elit, Prafull Ghatage, Amit M. Oza, Marie Plante, Diane Provencher, Johanne I. Weberpals, Stephen Welch, Anne Floquet, Laurence Gladieff, Florence Joly, Alexandra Léary, Alain Lortholary, Jean‐Pierre Lotz, Jacques Médioni, Olivier Trédan, Benoît You, Ayşe Balat, Claudia Hänle, Petra Krabisch, Tanja Neunhöffer, Martin Pölcher, Pauline Wimberger, A Amit, Svetlana Kovel, Michelle Leviov, Tamar Safra, Ronnie Shapira‐Frommer, Salomon M. Stemmer, Alessandra Bologna, Nicoletta Colombo, Domenica Lorusso, Sandro Pignata, Roberto Sabbatini, Giovanni Scambia, Stefano Tamberi, Claudio Zamagni, Peter C.C. Fong, Anne O’Donnell, Margarita Amenedo, A. Casado Herráez, Jesús García-Donás, E.M. Guerra, Ana Oaknin, Isabel Palacio, Ignacio Romero, A Sanchez, Susana Banerjee, Andrew R. Clamp, Yvette Drew, Hani Gabra, D Jackson, JA Ledermann, Iain A. McNeish, C. A. Parkinson, Melanie Powell, Carol Aghajanian
Follow-up after primary therapy for endometrial cancer: A systematic review
Michael Fung‐Kee‐Fung, Jason Dodge, Laurie Elit, Himu Lukka, Alex Chambers, Tom Oliver
Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group
Amit M. Oza, Laurie Elit, Ming‐Sound Tsao, Suzanne Kamel‐Reid, Jim Biagi, Diane Provencher, Walter H. Gotlieb, Paul Hoskins, Prafull Ghatage, Katia Tonkin, Helen Mackay, J. Mazurka, Joana Sederias, Percy Ivy, Janet Dancey, Elizabeth A. Eisenhauer
Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials
Ignace Vergote, Corneel Coens, Matthew Nankivell, Gunnar B. Kristensen, Mahesh Parmar, Tom Ehlen, Gordon C. Jayson, Nick Johnson, Ann Marie Swart, René H.M. Verheijen, W. Glenn McCluggage, Timothy Perren, Pierluigi Benedetti Panici, Gemma G. Kenter, Antonio Casado, César Mendiola, Gavin Stuart, N.S. Reed, Sean Kehoe, Claes Tropé G., Stephen Dobbs, Sharadah Essapen, P. Hoskins, John Green, Edward D. Gilby, Marchien van Baal, Jeremy Twigg, Maria E.L. van der Burg, Keith Godfrey, Ángel J. Lacave, Roberto Angioli, Rahul Nath, K. Chin, Charles Redman, Robert Lotocki, Adeola Olaitan, Berit Jul Mosgaard, Gordon Rustin, Thomas Ind, Mojca Persic, Martin Hogg, Jacobus van der Velden, Jonathan A. Ledermann, Peter Sykes Peter Sykes, Krishnawam Madhavan, Päivi Kannisto, V Hird, Anthony C. Evans, R. Sandvei R., Philippe Gauthier, Derek Cruickshank, P.B. Ottevanger, Sheila E. Pearson, Henry C Kitchener, Marcia Hall, Paul Bessette, S. Pecorelli, Eva Gerdin, Tito Lopes, Andrew Fish, Clare Barlow, Koen Van Eygen, Anne Floquet, Bengt Tholander, Nurdan Gül, Robert Gornall, David Luesley, P. H. Kirwan, Paul Symonds, Richard Henry, David Poole, Ian McNeish, M A Hocking, Al Sammaraie, P Speiser, Éric Leblanc, J.A. Green, C Fernández Oliveira, Robert Grimshaw, Paolo Zola, David E. Parkin, David Luesley, Martin Lamb, Anne Hong, Alan Gillespie, Abdel Hamid, Ahmed Ahmed, Marie Plante, B. De Valk, A Nordin, Andrew R. Clamp, D Díaz Pérez, Graham Dark, Michelle Ferguson, Carol MacGregor, G. Skailes, Rachel Jones, Alan Gillespie, G. Cawdell, Simon Leeson
Optimal Chemotherapy Treatment for Women with Recurrent Ovarian Cancer
Michael Fung‐Kee‐Fung, Thomas R. Oliver, Laurie Elit, Amit M. Oza, Hal W. Hirte, Peter Bryson, on behalf of the Gynecology Cancer Disease Site Group of Cancer Care Ontario’s Program in Evidence-Based Care